- Home
- OCX
OCX
Oncocyte Corporation
as 05-09-2025 4:00pm EST
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $4.42 | AVG Volume (30 days): | 43.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.92 - $4.75 | Next Earning Date: | 05-19-2025 |
| Revenue: | $1,881,000 | Revenue Growth: | 25.15% |
| Revenue Growth (this year): | -45.03% | Revenue Growth (next year): | 274.47% |
Latest Oncocyte Corporation News
OCX Breaking Stock News: Dive into OCX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Oncocyte to Release First Quarter 2025 Results on May 12, 2025
GlobeNewswire
9 days ago
Oncocyte Provides Positive Update on Clinical Trial Progress
GlobeNewswire
10 days ago
Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity
GlobeNewswire
a month ago
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
2 months ago
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
GlobeNewswire
2 months ago
Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
Insider Monkey
3 months ago
OncoCyte Corporation (OCX): Among Cheapest Stocks Insiders Are Buying Recently
Argus Research
3 months ago
Daily – Vickers Top Buyers & Sellers for 02/13/2025
Compare OCX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OCX Oncocyte Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.